View in EDS HTML Full Text PDF Full Text

Mitochondrial Plasticity Promotes Resistance to Sorafenib and Vulnerability to STAT3 Inhibition in Human Hepatocellular Carcinoma.

Saved in:
Bibliographic Details
Title: Mitochondrial Plasticity Promotes Resistance to Sorafenib and Vulnerability to STAT3 Inhibition in Human Hepatocellular Carcinoma.
Authors: Pandit SK; Tumor Biology and Experimental Therapeutics Program, Institute of Oncology Research, Università della Svizzera italiana, 6500 Bellinzona, Switzerland., Sandrini G; Tumor Biology and Experimental Therapeutics Program, Institute of Oncology Research, Università della Svizzera italiana, 6500 Bellinzona, Switzerland., Merulla J; Tumor Biology and Experimental Therapeutics Program, Institute of Oncology Research, Università della Svizzera italiana, 6500 Bellinzona, Switzerland., Nobili V; Tumor Biology and Experimental Therapeutics Program, Institute of Oncology Research, Università della Svizzera italiana, 6500 Bellinzona, Switzerland., Wang X; Tumor Biology and Experimental Therapeutics Program, Institute of Oncology Research, Università della Svizzera italiana, 6500 Bellinzona, Switzerland., Zangari A; Tumor Biology and Experimental Therapeutics Program, Institute of Oncology Research, Università della Svizzera italiana, 6500 Bellinzona, Switzerland., Rinaldi A; Tumor Biology and Experimental Therapeutics Program, Institute of Oncology Research, Università della Svizzera italiana, 6500 Bellinzona, Switzerland., Shinde D; Tumor Biology and Experimental Therapeutics Program, Institute of Oncology Research, Università della Svizzera italiana, 6500 Bellinzona, Switzerland., Carbone GM; Tumor Biology and Experimental Therapeutics Program, Institute of Oncology Research, Università della Svizzera italiana, 6500 Bellinzona, Switzerland., Catapano CV; Tumor Biology and Experimental Therapeutics Program, Institute of Oncology Research, Università della Svizzera italiana, 6500 Bellinzona, Switzerland.
Source: Cancers [Cancers (Basel)] 2021 Nov 30; Vol. 13 (23). Date of Electronic Publication: 2021 Nov 30.
Publication Type: Journal Article
Journal Info: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 34885140
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Mitochondrial Plasticity Promotes Resistance to Sorafenib and Vulnerability to STAT3 Inhibition in Human Hepatocellular Carcinoma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Pandit+SK%22">Pandit SK</searchLink>; Tumor Biology and Experimental Therapeutics Program, Institute of Oncology Research, Università della Svizzera italiana, 6500 Bellinzona, Switzerland.<br /><searchLink fieldCode="AU" term="%22Sandrini+G%22">Sandrini G</searchLink>; Tumor Biology and Experimental Therapeutics Program, Institute of Oncology Research, Università della Svizzera italiana, 6500 Bellinzona, Switzerland.<br /><searchLink fieldCode="AU" term="%22Merulla+J%22">Merulla J</searchLink>; Tumor Biology and Experimental Therapeutics Program, Institute of Oncology Research, Università della Svizzera italiana, 6500 Bellinzona, Switzerland.<br /><searchLink fieldCode="AU" term="%22Nobili+V%22">Nobili V</searchLink>; Tumor Biology and Experimental Therapeutics Program, Institute of Oncology Research, Università della Svizzera italiana, 6500 Bellinzona, Switzerland.<br /><searchLink fieldCode="AU" term="%22Wang+X%22">Wang X</searchLink>; Tumor Biology and Experimental Therapeutics Program, Institute of Oncology Research, Università della Svizzera italiana, 6500 Bellinzona, Switzerland.<br /><searchLink fieldCode="AU" term="%22Zangari+A%22">Zangari A</searchLink>; Tumor Biology and Experimental Therapeutics Program, Institute of Oncology Research, Università della Svizzera italiana, 6500 Bellinzona, Switzerland.<br /><searchLink fieldCode="AU" term="%22Rinaldi+A%22">Rinaldi A</searchLink>; Tumor Biology and Experimental Therapeutics Program, Institute of Oncology Research, Università della Svizzera italiana, 6500 Bellinzona, Switzerland.<br /><searchLink fieldCode="AU" term="%22Shinde+D%22">Shinde D</searchLink>; Tumor Biology and Experimental Therapeutics Program, Institute of Oncology Research, Università della Svizzera italiana, 6500 Bellinzona, Switzerland.<br /><searchLink fieldCode="AU" term="%22Carbone+GM%22">Carbone GM</searchLink>; Tumor Biology and Experimental Therapeutics Program, Institute of Oncology Research, Università della Svizzera italiana, 6500 Bellinzona, Switzerland.<br /><searchLink fieldCode="AU" term="%22Catapano+CV%22">Catapano CV</searchLink>; Tumor Biology and Experimental Therapeutics Program, Institute of Oncology Research, Università della Svizzera italiana, 6500 Bellinzona, Switzerland.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101526829%22">Cancers</searchLink> [Cancers (Basel)] 2021 Nov 30; Vol. 13 (23). <i>Date of Electronic Publication: </i>2021 Nov 30.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22MDPI%22">MDPI </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101526829 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>2072-6694 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220726694%22">20726694 </searchLink><i>NLM ISO Abbreviation: </i>Cancers (Basel) <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34885140
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3390/cancers13236029
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Mitochondrial Plasticity Promotes Resistance to Sorafenib and Vulnerability to STAT3 Inhibition in Human Hepatocellular Carcinoma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Pandit SK
      – PersonEntity:
          Name:
            NameFull: Sandrini G
      – PersonEntity:
          Name:
            NameFull: Merulla J
      – PersonEntity:
          Name:
            NameFull: Nobili V
      – PersonEntity:
          Name:
            NameFull: Wang X
      – PersonEntity:
          Name:
            NameFull: Zangari A
      – PersonEntity:
          Name:
            NameFull: Rinaldi A
      – PersonEntity:
          Name:
            NameFull: Shinde D
      – PersonEntity:
          Name:
            NameFull: Carbone GM
      – PersonEntity:
          Name:
            NameFull: Catapano CV
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 30
              M: 11
              Text: 2021 Nov 30
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-print
              Value: 2072-6694
          Numbering:
            – Type: volume
              Value: 13
            – Type: issue
              Value: 23
          Titles:
            – TitleFull: Cancers
              Type: main
ResultId 1